Matarin Capital Management’s Cerence CRNC Stock Holding History

Matarin Capital Management’s Portfolio CRNC Stock Details CRNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-48,156	Closed	-$742K	–	201
2020 Q1	$742K	Buy	+48,156	New	+$1.01M	0.12%	169

Other funds holding CRNC

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Isomer Partners New York $74.3M AUM 23.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Matarin Capital Management's CRNC Position: Q2 2020 in Review

Matarin Capital Management sold out of Cerence (CRNC) in Q2 2020, closing a stake of 48,156 shares — an estimated $742K sold.

Matarin Capital Management first reported a position in CRNC in Q1 2020 and held it in 1 quarter. The position peaked at $742K in Q1 2020. 241 funds tracked by Wall St. Rank hold CRNC as of Q2 2020.

Matarin Capital Management reported no remaining Cerence position as of Q2 2020 after selling out during the quarter.
Matarin Capital Management sold 48,156 Cerence shares in Q2 2020, an estimated $742K.
Matarin Capital Management first reported a position in Cerence in Q1 2020 and held it in 1 quarter.
Matarin Capital Management's Cerence position peaked at $742K in Q1 2020.
241 funds tracked by Wall St. Rank held Cerence as of Q2 2020.

Based on Matarin Capital Management's 13F filing for Q2 2020, filed 6 Aug 2020.